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Pdx1 is a homeobox-containing transcription factor
that plays a key role in pancreatic development and
adult b cell function. In this study, we traced the
fate of adult b cells after Pdx1 deletion. As expected,
b-cell-specific removal of Pdx1 resulted in severe
hyperglycemia within days. Surprisingly, a large
fraction of Pdx1-deleted cells rapidly acquired ultra-
structural and physiological features of a cells, indi-
cating that a robust cellular reprogramming had
occurred. Reprogrammed cells exhibited a global
transcriptional shift that included derepression of
the a cell transcription factor MafB, resulting in a
transcriptional profile that closely resembled that of
a cells. These findings indicate that Pdx1 acts as
a master regulator of b cell fate by simultaneously
activating genes essential for b cell identity and
repressing those associated with a cell identity. We
discuss the significance of these findings in the
context of the emerging notion that loss of b cell
identity contributes to the pathogenesis of type 2
diabetes.
INTRODUCTION
The mammalian pancreas is composed of an exocrine com-
partment, which is responsible for secreting digestive enzymes
into the intestine, and an endocrine compartment, which is
responsible for the production and regulated secretion of
hormones into the bloodstream. Pancreatic endocrine cells
cluster together within the islets of Langerhans, which contain
five different types of cells, each producing a distinct hormone
product. The most essential of these is the b cell, which is the
only mammalian cell type capable of making insulin for regu-
lating blood glucose uptake in peripheral tissues. Diabetes is aCell Mprevalent, lifelong, and chronic illness caused by either the
lack of (i.e., type 1) or dysfunction of (i.e., type 2) b cells. In
addition, the production of the hormone glucagon from islet a
cells—a hormone that normally balances insulin action—is
dysregulated in type 2 diabetes (T2DM), the preponderant form
of the disease.
All pancreatic compartments are derived from a set of pro-
genitor cells that express the pancreas and duodenum homeo-
box1 (Pdx1) gene during pancreas development (Gu et al.,
2002). Pdx1 is the first transcription factor produced in the
developing pancreas, and humans or mice lacking this factor
suffer from pancreatic agenesis due to the inability to produce
duct, exocrine, or endocrine cell types (Jonsson et al., 1994;
Offield et al., 1996; Stoffers et al., 1997). Notably, Pdx1 ex-
pression becomes confined to b cells over the course of
development. Conditional removal of Pdx1 from forming b cells
using insulin-driven Cre lines results in hyperglycemia, com-
promised insulin+ (Ins+) cells, and increased glucagon+ (Glu+)
cells (Ahlgren et al., 1998; Gannon et al., 2008). However, the
cellular and molecular mechanisms underlying this requirement
for Pdx1 in b cells are unknown. Notably, the increase in Glu+
cell numbers upon embryonic Pdx1 deletion in the latter study
(Gannon et al., 2008) was concluded to result from enhanced
proliferation.
Several lines of evidence suggest that a cells and b cells
share a close developmental relationship. First, early pancreas
development is characterized by a wave of differentiation that
gives rise to cells that express both glucagon and insulin,
although these cells do not go on to populate the islet (Herrera,
2000). Second, cell ablation studies in which more than 99% of
b cells were killed demonstrated that a cells can be converted
into Ins+ cells (Thorel et al., 2010). Third, b-cell-specific deletion
of DNA methyltransferase1 (Dnmt1) results in their conversion
to Glu+ cells through an Nkx2.2-dependent derepression of the
a cell determination factor Arx (Dhawan et al., 2011; Papizan
et al., 2011). Fourth, forced Pax4 expression in a cells promotes
conversion into b-like cells (Collombat et al., 2009). Finally,
forced expression of Pdx1 in embryonic endocrine progenitor
cells results in conversion of perinatal a cells into b-like cellsetabolism 19, 259–271, February 4, 2014 ª2014 Elsevier Inc. 259
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Figure 1. Adult Islet b Cells Lose Their Identity and Acquire Islet a-like Features following Pdx1 Deletion
(A) Schematic showing the strategy for Pdx1 deletion and lineage tracing. Mice with a ‘‘floxed’’ allele of Pdx1 and a Cre-sensitive YFP reporter were crossed to
RIP-CreER mice. Treatment of animals with tamoxifen (TAM) resulted in simultaneous deletion of exon 2 from both copies of Pdx1 and permanent heritable
labeling of the cell with YFP. Mice having one ‘‘floxed’’ and one wild-type allele of Pdx1 were used as controls for all experiments.
(B) Fasting blood glucose levels and glucose tolerance tests performed 4 weeks after TAM administration to 4-week-old mice with two ‘‘floxed’’ copies of Pdx1
(‘‘PKO’’ mice) or controls.
(C) Immunofluorescent images taken 4 weeks after TAM administration showing loss of Pdx1, Nkx6.1, and Glut2 in PKO cells compared to control. Note
the persistence of Pdx1 in some YFP cells from PKO islets (but the complete absence of staining in YFP+ cells), indicating that YFP is a reliable reporter for
Pdx1-deleted cells.
(legend continued on next page)
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Pdx1 Maintains Adult b Cell Identitythrough an intermediate stage characterized by insulin/glucagon
coexpression (Yang et al., 2011). Importantly, however, such
changes in cell phenotype—i.e., conversion from a Glu+ cell
to an Ins+ cell—cannot on their own serve as evidence of
‘‘reprogramming,’’ since a genuine, stable cellular interconver-
sion involves a transformation far more complex than a change
in expression of one or even a few cell-type-specific markers.
Presently, the precise cellular state that the b-like cells adopt
under these various conditions remains poorly defined.
Recently, Talchai et al. (2012) reported that mice with a con-
ditional b-cell-specific deletion of the FoxO1 transcription fac-
tor exhibit a loss of b cell identity, with affected cells adopting
either an Ngn3+ hormone progenitor-like or a-like state. More-
over, they proposed that the pathogenesis of human T2DM
involved both b cell dedifferentiation to NGN3-like progenitor
cells and transdifferentiation events. In the current study, we
conditionally and specifically deleted Pdx1 in mature b cells
and followed their fate with a lineage tracer. As predicted
from the earlier experiments using insulin-Cre, Pdx1 deletion
resulted in a loss of b cell identity. Surprisingly, however, within
days these cells acquired ultrastructural, physiological, and
global transcriptional signatures of b-to-a-cell reprogramming,
without enhanced Ngn3 expression. The islet a-cell-enriched
MafB transcription factor was among the most significantly
upregulated genes associated with this conversion, whereas
induction of other key a cell transcription factors (i.e., Arx and
Brn4) was not observed. We found that Pdx1 normally binds
within the MafB and glucagon promoters in b cells and ob-
tained evidence that MafB derepression in Pdx1-depleted cells
was responsible for gene activation. Significantly, these results
highlight the importance of b cell Pdx1 in actively inhibiting a
cell identity and provide mechanistic insight into repressive
mechanisms involved in regulating islet b cell identity and func-
tion, information that is relevant to the loss of Ins+ cell mass
in T2DM and efforts to generate b-like cells for therapeutic
treatment.
RESULTS
Pdx1 Maintains b Cell Identity
Several mechanisms could account for the previous observation
that Pdx1 loss in b cells leads to diabetes (Ahlgren et al., 1998;
Gannon et al., 2008). These include (1) b cell death, (2) loss of
b cell identity factors resulting in dysfunctional b-like cells, or
(3) transdifferentiation to another cell type. To distinguish
between these possibilities, we deleted Pdx1 in adult b cells
and tracked their fate using a RosaYFP lineage label. This was
achieved by generating RIP-CreER; Pdx1fl/fl; RosaYFP mice
(PKOmice). Within the pancreas, the RIP-CreER strain mediates(D) Immunofluorescent images taken 4 weeks after TAM administration showing
staining in YFP+ cells from PKO islets.
(E) Relative abundance of transcripts encoding b cell genes (Pdx1, Nkx6.1, Ins1, G
sorting of YFP+ cells from control and PKO islets (n = 3 animals each group).
(F) Immunofluorescent images taken 4 weeks after TAM administration showing e
In control islets, YFP staining does not overlap with Glu, MafB, or Arx staining.
(G) Relative abundance of transcripts encoding a cell genes (MafB, Glucagon, an
YFP+ cells from control and PKO islets (n = 3 animals each group). Bar graph data
***p<0.001 by two-tailed Student’s t test. Scale bar indicates 100 mM. See also F
Cell Mrecombination exclusively in b cells (Dor et al., 2004; data not
shown), and administering tamoxifen (TAM) to 1 month-old
mice resulted in the simultaneous deletion of Pdx1 and expres-
sion of the YFP lineage label specifically in b cells (Figures 1A
and S1A available online). Thirty days after Pdx1 deletion, PKO
mice displayed overt diabetes, as indicated by basal hyperglyce-
mia and an abnormal response to glucose challenge (Figure 1B).
Importantly, these changes in glucose tolerance were not due
to haploinsufficiency for Pdx1, as TAM-treated RIP-CreER;
Pdx1f//+; RosaYFP mice exhibited a normal basal glucose level
and normal glucose clearance rates (Figure S1B). We confirmed
efficient deletion by immunostaining for Pdx1 protein, which
demonstrated a loss of nuclear staining in over 90% of islet cells
(Figures 1Ca and 1Cd). Importantly, the few islet cells that
retained Pdx1 were YFP negative, indicating that YFP staining
serves as a robust surrogate for cells that have lost Pdx1.
Notably, YFP+ Pdx1-deficient cells were still present in abun-
dance in PKO islets; hence, Pdx1 is not absolutely required for
adult b cell survival (Figure 1C). Such cells no longer expressed
b-cell-specific markers such as Ins, Nkx6.1, and Glut2 (Figures
1C and 1D). These expression changes were confirmed at the
RNA level in sorted YFP+ cells from PKO and control islets
(Figure 1E). Thus, as expected, Pdx1 deficiency is associated
with a loss of b cell identity.
We next tested the hypothesis that b cells adopt another
endocrine cell fate upon Pdx1 loss. Hence, we performed coim-
munostaining for YFP and a panel of endocrine hormones in
PKO mice. Costaining of YFP with pancreatic polypeptide (PP)
or somatostatin did not reveal overlap (Figure S1C). However,
substantial portions of the lineage-labeled Pdx1-deficient cells
expressed both YFP and glucagon (Figures 1Fa–1Fd, S2A,
and S2C). We then examined PKO islets for the expression of
MafB and Arx, two transcription factors that are critical for the
development of murine a cells (Bramswig and Kaestner,
2011). MafB, whose expression is normally limited to a cells in
adult islets (Artner et al., 2006) (Figures 1Fb and 1Fc), was
clearly evident in the YFP+ cells of PKO animals (Figures 1Ff
and 1Fg). Notably, the expression of Arx, a transcription factor
required for a cell development (Collombat et al., 2003), did
not change in newly formed Glu+ MafB+ YFP+ cells (Figures
1Fd and 1Fh). This pattern was confirmed at the RNA level on
sorted cells from PKO and control islets (Figure 1G). Moreover,
we were unable to detect any effect after Pdx1 deletion on
expression of Ngn3, a key regulator of endocrine progenitor
cell formation during development that was recently shown to
be activated in islet b cells in rodent T2DM models (Talchai
et al., 2012) (Figure S3). These results show that MafB and
glucagon, but not Arx or Ngn3, are induced in b cells that
have lost Pdx1.loss of insulin (Ins) in PKO cells compared to control. Note the lack of insulin
lut2, andMafA), as measured by qPCR following islet isolation and single-cell
xpression of glucagon (Glu) and MafB, but not Arx, in YFP+ cells in PKO islets.
d Arx), as measured by qPCR following islet isolation and single-cell sorting of
are presented as mean ±SD in this and subsequent figures. *p<0.05; **p<0.01;
igure S1 and Table S1.
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Pdx1 Maintains Adult b Cell IdentityChanges in Cell Identity Occur Rapidly following Pdx1
Deletion
A time course analysis was performed to address the dynamics
of these phenotypic changes. PKO and control animals were in-
jected with two consecutive daily doses of TAM and processed
at 0, 2, 3, or 5 days afterwards. Low levels of YFP expression
were detected as early as 2 days post-TAM, reflecting a short
lag between genomic recombination and the accumulation
of YFP protein (Figures 2Ai–2Aj). YFP staining subsequently
increased, such that the majority of islet cells were YFP+ by
5 days post-TAM (Figure 2Ak and 2Al). In parallel, Glu staining
became prevalent in the center of islets (Figures 2Ae–2Ah and
S2A), while Ins staining was rapidly lost (Figures 2Aa–2Ad and
S2B) and remained persistently absent (Figure S2C). A loss in
mouse insulin I and II mRNA levels was also clearly evident in
PKO islets as early as 5 days post-TAM, with a more dramatic
decrease observed at 30 days post-TAM (Figure S2D).
Approximately 35% of YFP+ cells costained for Glu 5 days
after TAM, a percentage that decreased to under 15% by
30 days post-TAM (Figure 2B). However, this change in Glu+
YFP+ cell number was not due tomarked changes in proliferation
or apoptosis (Figures S1D and S1E). Although the majority of
islet cells in the 5 day period following TAM treatment expressed
either Ins or Glu, as many as 20% of the Ins+ cells were also Glu+
(Figures 2C and S2B). These results suggest that conversion
from an Ins+ to a Glu+ cell occurs rapidly following removal of
Pdx1 and that cohormone-producing cells represent an inter-
mediate cellular stage.
Pdx1-Deficient Cells Acquire Ultrastructural Features
of a Cells
Islet a cells and b cells reside in distinct locations in rodents, with
b cells occupying the islet center and a cells residing in an outer
ring. Moreover, a and b cells package their hormone products
into ultrastructurally distinct secretory granules that can be
distinguished by transmission electron microscopy. Specifically,
mature ‘‘b granules’’ are typified by electron-dense insulin crys-
tals surrounded by a clear ‘‘halo,’’ whereas glucagon-containing
‘‘a granules’’ lack any such halo (Figure 3A).
To determine whether there was a change in cellular
ultrastructure following Pdx1 deletion, we isolated islets from
1-month-old control and PKO mice and scored cells according
to granule type. In control islets, approximately 3% of cells
contained a granules; as expected, these cells were found
exclusively at the islet periphery (Figures 3B and 3C). By
contrast, a-granule-containing cells were readily detected in
the center of PKO islets, a location where they would not
normally be found (e.g., Figure 3B, PKO cell #1). Quantification
revealed that approximately 30% of islet cells in PKO animals
contained a granules, a 10-fold increase over control (Figure 3C).
Thus, Pdx1 deletion in b cells results in their conversion into
Glu+ cells that have morphological features of a cells.
Pdx1-Deficient Cells Acquire Physiological Features
of a Cells
PKO mice were subjected to a number of physiological tests
to determine the functional consequences of Pdx1 loss. Under
normal circumstances, b cells take up glucose through the
Glut2 transporter and sense glucose levels through glucokinase262 Cell Metabolism 19, 259–271, February 4, 2014 ª2014 Elsevier In(hexokinase 4), resulting in depolarization via an ATP-dependent
potassium channel, calcium influx, and exocytosis of insulin
granules. Glycine or mixed amino acids (AAM) cause glucagon
release from a cells by similar processes (Li et al., 2012).
To examine the physiologic features of lineage-traced b cells
that had lost Pdx1, we measured changes in calcium flux at
the single-cell level using Fura-2, a sensitive indicator of
intracellular calcium (Li et al., 2010, 2012). First, we compared
the calcium flux response of individual cells isolated from
2-month-old control mice to a glucagon secretagogue (either
1mM glycine or 4 mM AAM) or an insulin secretagogue (10 mM
glucose). For this analysis, we examined two classes of cells:
YFP+ b cells and YFP-negative non-b cells. As predicted, a
change in intracellular calcium was principally observed in
YFP+ cells treated with glucose (Figure 4A, cell #3) and YFP-
negative cells treated with glycine (Figure 4A, cell #13), as the
glycine receptor is not expressed on b cells (Li et al., 2012).
Next, we tested the calcium response of YFP+ islet cells from
2-month-old control and TAM-treated PKO animals. In addition
to cells that responded to glucose but not glycine (b cells),
or only to glycine (a cells), we also found a third category of
cells in PKO islets that responded to both glycine and glucose
(Figure 4B, cell #6).
We then quantified the calcium responsiveness in individual
cells. In control islets, stimulation occurred in more than 85%
of cells after glucose treatment and in only 5% of cells after
treatment with AAM, consistent with the expected abundance
of a cells and b cells in normal islets (Figure 4C). In PKO islets,
by contrast, there was a significant increase within 5 days of
Pdx1 deletion in the percentage of cells that responded to
AAM, but not glucose (Figure 4C). In addition, approximately
40% of cells exhibited calcium flux in response to both glucose
and glycine, a behavior that was rarely observed in control islets
(Figure 4C). Importantly, PKO islets lost the ability to secrete
insulin and gained the ability to secrete glucagon, either sponta-
neously or in response to amino acids (Figure S4). These results
indicate that the new Glu+ cells in PKO mice respond to
external secretion stimuli in a manner that is a hybrid between
the normal a and b cell responses, resulting in a-like cells that
secrete glucagon in a nonphysiological manner.
Global a-Cell-like Transcriptional Reprogramming
Occurs in Pdx1-Deleted Islet b Cells
Although our ultrastructural and functional studies suggested
that PKO b cells turn into cells with many of the features of a
cells, important differences relative to endogenous cells were
also found upon initial characterization. First, only 35% of the
Pdx1-deleted YFP+ cells stained for Glu, with the bulk of the
remainder lacking staining for any hormone. Second, Glu+
YFP+ cells produced just one of the two key transcription factors
strongly associated with a cell development and function—
MafB, and not Arx. To get a more complete picture of the
transcriptional changes associated with Pdx1 loss in b cells,
we conducted an mRNA microarray comparing normal islet
b cells and a cells to the reprogrammed cells from PKO mice.
To enrich for genes directly affected by Pdx1 loss, we chose
the early time point for analysis of PKO mice (5 days after
TAM administration). Control mRNA profiling was performed
on FACS-sorted islet YFP+ a cells and b cells obtained fromc.
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Figure 2. Dynamics of Islet Insulin and Glucagon Expression following Pdx1 Deletion
(A) Representative images showing costaining for YFP, glucagon, and insulin at either 0, 2, 3, or 5 days following TAM administration to PKO animals. Insets in (p)
show cells that coexpress YFP and glucagon.
(B) Quantification of Glu/YFP ‘‘double positive’’ cells as a fraction of the total number of YFP+ cells in control or PKO animals either 5 days after TAM treatment
or 30 days after TAM treatment. No Glu+YFP+ cells were seen in control animals (n = 4 each group).
(C) Quantification of Ins/Glu ‘‘double positive’’ cells as a fraction of the total number of Ins+ cells in control or PKO animals either 5 days after TAM treatment
or 30 days after TAM treatment (n = 4 each group). Scale bar indicates 50 mM. See also Figures S2 and S3.
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Figure 3. PKO Islets Exhibit Ultrastructural Changes
(A) Electron micrographs showing typical b granules (left) and a granules (right).
(B) Low and highmagnification electronmicrographs of control and PKO islets (outlined in black). In a control islet (left), cells in the interior (cells #1 and #2) contain
b granules while cells at the margin (cell #3) contain a granules. In a PKO islet (right), cells containing a granules can be found in the islet center (cell #1; outlined in
yellow).
(C) Quantification of cells containing a granules as a percentage of total islet cells, comparing control and PKO animals. (n = 3 animals each group; greater than 6
islets counted per animal). Scale bars indicate 100 mM. High magnification indicates 20 mM.
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Pdx1 Maintains Adult b Cell Identity2-month-old glucagon-Cre; RosaYFP and RIP-CreER; Pdx1fl/+,
RosaYFP mice, respectively (Figure S5).
Analysis of 28,350 transcripts revealed 416 genes that were
differentially expressed across the three groups, with a false
discovery rate (FDR) of less than 0.1 (Tables S1 and S2). When
hierarchical clustering was applied, b cells had a distinct
transcriptional profile, while a and YFP+ PKO cells showed sig-
nificant overlap (Figure 5A). By filtering gene sets to focus on
groups that exhibited a greater than 2-fold change in expression
(and FDR<0.1), 253 genes were found to be differentially ex-
pressed between b cells and a cells (Table S3), while 51 genes
were found to be differentially expressed between b cells and
PKO cells (Table S4). Notably, a total of 36 genes were differen-264 Cell Metabolism 19, 259–271, February 4, 2014 ª2014 Elsevier Intially expressed in both of these datasets (Table S5); of these,
MafB showed the greatest statistical expression difference be-
tween PKO and b cells (Figure 5B). We confirmed this change
in the expression of MafB and other selected targets at the tran-
scriptional level by qPCR. Transcripts levels for Pdx1, Ins1, and
Glut2 were all significantly reduced in PKO cells (Figure 5C).
Conversely, MafB and glucagon transcripts were present at
increased levels in PKO cells, although not to the levels present
in a cells (Figure 5C). Arx transcript levels were unchanged in
5 day PKO islets, consistent with our prior observations from
islets 30 days after Pdx1 deletion. These results suggest that
the mRNA profile of PKO cells closely resembles that of a cells,
despite the absence of Arx.c.
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Figure 4. Pdx1 Deletion Results in Cells with Physiological Features of a Cells
(A) Tracing of calcium flow in islet cells from control animals measured by dual-wavelength fluorescence microscopy. A YFP+ cell (cell #3), representative of a b
cell, shows responsiveness to 10 mM glucose but not 1 mM glycine, while a YFP cell (cell #13), representative of an a cell, shows responsiveness to glycine but
not glucose. Images on the left show YFP- and Fura-2-derived fluorescence of cells measured for the tracings (arrows).
(B) Tracing of calcium flow in YFP+ islet cells from PKO animals. PKO islets contain YFP+ cells that exhibit responsiveness to glycine (cell #2) and cells that exhibit
responsiveness to both glycine and glucose (cell #6).
(C) Quantification of results from (A) and (B). The response of cells from control islets, islets from PKO animals 5 days post-TAM, or islets from PKO animals
5 weeks post-TAM was determined and plotted according to their glucose, glycine, dual responsiveness, or lack of responsiveness as a percentage of the total
number cells counted. For each experimental animal, measurements were taken from at least ten cells. See also Figure S4.
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Maintenance of b Cell Identity
MafB is required for the production of both a and b cells during
pancreas organogenesis, although expression is silenced in b
cells soon after birth (Artner et al., 2007, 2010; Nishimura et al.,
2006). MafB binds to, and directly activates hormone gene
expression in, these cells (Artner et al., 2006). In contrast,
sustained production of closely related MafA in islet b cells is
essential for production of functional cells (Artner et al., 2006,
2007, 2010; Zhang et al., 2005).
The dramatic induction of MafB in Glu+ PKO cells led us to
hypothesize that this factor may be a driving force behind the
shift towards an a-like identity. To investigate this possibility, a
recombinant adenovirus-producing siRNA against Pdx1 was
used to determine if depletion also induced MafB expression in
the rat insulinoma Ins-1 cell line. Both MafB and Glu expression
were rapidly upregulated, and insulin expression was down-
regulated, upon Pdx1 knockdown (Figure 6A). Expression of aCell Mdominant-negative-acting Pdx1 in Ins-1 cells has been shown
to selectively induce Glu expression, but not Arx or Brn4
(Wang et al., 2001), a result also observed here (data not shown).
Because these properties closely resembled those of PKO cells,
we next examined the influence of Pdx1 on MafB transcription
and the significance ofMafB protein induction to Glu expression.
Chromatin immunoprecipitation sequencing (ChIP-seq)
analysis performed in Min6 b cell lines identified Pdx1 binding
around800 and1,500 bp upstreamof theMafB coding region
(data not shown). Gel mobility shift assays were next performed
with bTC3 nuclear extract to determine whether Pdx1 bound to
bioinformatically identified sites at 1,325/1,316 bp (i.e., Site
1) and 942/933 bp (Site 2) within these regions (Figure 6B).
Pdx1 binding was only observed at Site 2, as determined by
antibody addition and wild-type and mutant competitor analysis
(Figure 6C; data not shown). Moreover, ChIP studies demon-
strated that Pdx1 specifically bound to this region of the endo-
genous MafB gene in Min6 cells (Figure 6D). In addition, thisetabolism 19, 259–271, February 4, 2014 ª2014 Elsevier Inc. 265
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Figure 5. Pdx1 Deletion Leads to an Islet a Cell Transcriptional Reprogramming
(A) Heatmap showing relative expression of 416 genes that were differentially expressed in a microarray comparison of a cells, b cells, and PKO YFP+ cells
isolated 5 days after Pdx1 deletion. (See Experimental Procedures for microarray methodology.) By hierarchical clustering, b cells (green samples) constituted a
distinct group, whereas a cells (yellow samples) and PKO cells (blue samples) were more closely related.
(B) Venn comparison showing the subset of differentially expressed genes whose expression differed by more than 2-fold between groups in the microarray.
Using these criteria, a cells and b cells had 253 differentially expressed genes, and b cells and PKO cells had 51 differentially expressed genes, with an overlap of
36 genes. The four most significantly different are shown.
(C) Confirmation of differences in selected targets across the three sample groupsmeasured by qPCR. See also Figure S5 and Tables S1, S2, S3, S4, S5, and S6.
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Pdx1 Maintains Adult b Cell Identityexperiment illustrated the ability of Pdx1 to bind promoter-prox-
imal glucagon sequences spanning the G1 element associated
with Pdx1-mediated repression (Figure 6D) (Wang et al., 2001).
These results strongly suggest that Pdx1 directly represses
MafB expression in islet b cells.
To investigate the importance of MafB in glucagon activation
following Pdx1 depletion in b cells, we developed siRNA
reagents to simultaneously eliminate Pdx1 and MafB proteins
from Ins1 cells. Under these circumstances, the stimulation of
glucagonmRNA and protein expression that normally accompa-
nied Pdx1 elimination in b cells was prevented (Figure 6E; data
not shown), strongly suggesting that MafB derepression was
responsible for glucagon induction. Furthermore, lentiviral deliv-
ery ofMafB cDNA to Ins-1 cells resulted in increased production
of glucagon transcripts, but not Ins1 or Arx (Figure 6F). Taken
together, these data demonstrate that MafB derepression is
responsible for the induction of glucagon, and likely other essen-
tial functional a cell genes in PKO islets.
DISCUSSION
Cell identity is maintained by the expression of self-reinforcing
transcriptional networks. Understanding the nature of these
networks is a central question in developmental biology,
but delineating the molecular mechanisms underlying cellular
identity also has broader implications. In the field of regenerative
medicine, for example, a detailed picture of the molecular
mechanisms that underlie cellular differentiation states could
facilitate cellular reprogramming for therapy. Likewise, deter-
mining how nuclear factors act to enforce one differentiation
program at the expense of another could have implications
for understanding degenerative diseases, in which loss of cell
identity may be associated with a loss of tissue function.
Our work provides new insight into Pdx1 function in adult
b cells. Using conditional gene ablation and lineage tracing,
we have shown that deletion of the Pdx1 transcriptional regu-
lator in b cells results in a rapid change in cellular differentiation
state. Within days of Pdx1 deletion, b cells lose multiple
markers of b cell identity, resulting in overt diabetes in PKO
animals. Importantly, b cells did not die following Pdx1 loss
but rather took on one of two phenotypes: an a-like phenotype,
characterized by the expression of glucagon and MafB, or a
loss of b cell identity, characterized by the absence of any
pancreatic hormone. The abundance of Pdx1YFP+ cells in
PKO islets, and the failure to detect an increase in cleaved
caspase3 staining in Pdx1-deleted b cells, suggests that
Pdx1 is not absolutely required for survival. Nevertheless, the
possibility remains that Pdx1 loss is associated with an unsta-
ble intermediate state that could lead to cellular loss over time,
a prospect consistent with the finding that the proportion of
Glu+YFP+ cells decreases from 35% to less than 15% between
d5 and d30 following Pdx1 deletion (Figure 2B). Within the
pancreas, RIP-CreER mediates recombination solely in the b
cells. However, RIP-Cre-mediated recombination has previ-
ously been described in extrapancreatic cells in the brain
(Wicksteed et al., 2010). Thus, it remains possible that Pdx1
deletion in cells outside of the pancreas could modestly
contribute in a non-cell-autonomous manner to the observed
phenotypes.Cell MWe are not the first to report cellular ‘‘reprogramming’’
between the a and b cell lineages. Glu+ cells become Ins+
following forced expression of Pdx1 or Pax4 (Collombat et al.,
2009; Yang et al., 2011). Moreover, Ins+ cells become Glu+
following deletion of Dnmt1 or FoxO1 (Dhawan et al., 2011;
Talchai et al., 2012) and in the setting of extreme b cell loss
(Thorel et al., 2010). Moreover, Ahlgren et al. (1998) and Gannon
et al. (2008) found that developmental deletion of Pdx1 by
insulin-Cre increased the Glu+ to Ins+ cell ratio. And most
recently, Bramswig and Kaestner (2011) demonstrated that
changes in histone methyltransferase activity could influence
b-to-a transdifferentiation. Hence, our finding that b cells acquire
a cell features following Pdx1 deletion is not unprecedented.
Importantly, however, these prior studies did not define the
extent to which such changes in cell phenotype represent a
global change in cell identity. As a consequence, changes in
cell phenotype observed following these manipulations might
have merely reflected b cells that had lost their identity and
become Glu+ rather than a ‘‘global’’ b-to-a-cell reprogramming
event. To address this possibility, we performed a set of rigorous
experiments to characterize the lineage-traced cells in detail. We
found that lineage-traced Pdx1-deleted b cells gained ultrastruc-
tural features of a cells (a granules), acquired many physiological
features of a cells (Glu secretion and calcium flux in response
to amino acids), and a transcriptional profile that was highly
similar to that of endogenous a cells. Based on these studies,
we believe that Pdx1 loss leads to the reprogramming of b cells
into cells that closely resemble a cells. Furthermore, we propose
that Pdx1 acts as a transcriptional repressor at the MafB locus
and that derepression of MafB is an important driver of this
b-to-a-cell reprogramming event.
Importantly, the reprogrammed cells we observe following
Pdx1 deletion differ in one significant respect from bona fide a
cells: they lack expression of the Arx transcription factor, a
marker of mature a cells. This result is surprising in the context
of reports that Dnmt1-mediated maintenance of b cell identity
is associated with methylation of the Arx locus (Dhawan et al.,
2011), and ectopic expression of Arx during embryonic develop-
ment causes pancreatic b-to-a-cell conversion (Collombat
et al., 2007). Our data suggest that adult islet a cells, in contrast
to their embryonic counterparts, can arise from b cells in an
Arx-independent manner, an idea supported by the recent
demonstration that Arx is not required for the maintenance of
islet a cell identity in adult animals (Wilcox et al., 2013). Appreci-
ating the differences in both the expression levels of these
two a cell identity products and the physiological secretion
properties of the GFP+ cells from TAM-treated PKO mice and
endogenous a cells, collaborative interactions between MafB
and Arx may be critical in controlling distinct, as well as similar,
parts of the a cell program (e.g., Pdx1 for MafB and Nkx2.2 for
Arx) (Papizan et al., 2011). As such, one would predict that
MafB is of greater value to islet a cells, considering its funda-
mental importance to glucagon transcription and the observa-
tions of Wilcox et al. (2013). In the future, it will be important to
further delineate the contributions of these two transcription
factors to the ‘‘transcriptional wiring’’ of the a cell.
Our results are reminiscent of the recent finding that FoxO1
deletion in rodent b cells results in hyperglycemia that is asso-
ciated with a loss of b cell identity and conversion into otheretabolism 19, 259–271, February 4, 2014 ª2014 Elsevier Inc. 267
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Pdx1 Maintains Adult b Cell Identityendocrine cell types, particularly Glu+ cells (Talchai et al., 2012).
An implication of that work, and the current study, is the possibil-
ity that loss of cell identity contributes at least partially to b cell
failure in T2DM, a scenario that contrasts with the prevailing
view that b cell failure is largely a consequence of an
apoptosis-driven reduction in b cell mass (Butler et al., 2007).
In support of the Talchai et al. (2012) findings, PDX1 and a small
subset of other key islet-enriched transcription factors were
found at dramatically reduced levels in human T2DM islet b cells
(Guo et al., 2013). Moreover, a recent study (Spijker et al., 2013)
has shown that isolated human b cells possess an intrinsic
ability to transdifferentiate into a cells. Our study is thus part of
a growing body of evidence which indicates that b cell dysfunc-
tion, and not merely loss of b cell mass, contributes to T2DM
pathogenesis.
We found no evidence that an endocrine progenitor cell state
was induced following Pdx1 deletion (e.g., Ngn3) (Figure S3).
Significantly, human T2DM islet samples did not have activated
levels of the progenitor cell regulators found in prior rodent
studies (i.e., NEUROGENIN 3, NANOG, POU5F1, and MYCL1)
(Guo et al., 2013), illustrating mechanistic differences between
species in their responsiveness to T2DM stress conditions.
Nevertheless, our observation that Pdx1 deletion leads to a
phenotype similar to the one seen in T2DM islets—characterized
by the loss of b-cell-enriched transcription factors and a
decrease or absence in insulin expression—is consistent with
the idea that changes in the differentiated b cell state play a
role in b cell failure. Of note, induction of MafB expression has
been observed in the b cells of glucose-intolerant mice fed a
high fat diet (Lu et al., 2012). Our findings hint at one mechanism
that could contribute to the a cell dysregulation and hypergluca-
gonemia that frequently accompany T2DM—the formation of
glucagon-secreting a-like cells that are not physiologically
regulated (Figure S4). Hence, it will be interesting to determine
if human T2DM islet a cells not only lack MAFB (Guo et al.,
2013) but also Arx.
A decrease in Pdx1 expression has previously been observed
in rodents with chronic hyperglycemia (Harmon et al., 1999;
Jonas et al., 1999) and more recently in human T2DM patients
(Guo et al., 2013), lending further support to the notion that
PDX1 loss contributes to this disease. Nevertheless, it is impor-
tant to stress that human T2DM pathogenesis is likely to be
multifactorial, involving both b cell loss and changes in b cell
identity and function following reduction in the expression of
b-cell-enriched transcription factors like PDX1 or NKX6.1 (TaylorFigure 6. MafB and Glucagon Transcription Is Stimulated in b Cells by
Levels Activating Glucagon
(A) Immunostaining of Min6 cells infected with adenoviruses expressing GFP or
immunofluorescence and western blotting) greatly intensifies MafB and glucago
(B) Schematic view of the two potential Pdx1 binding sites on the MafB promote
protein binding sequences are designated in red, Pdx1 only bound to MafB Site
(C) Results from EMSA using nuclear extracts (NE) from bTC3 cells showing Pdx1
Pdx1 antibody (a-Pdx1) addition, analysis was performed. The location of the Pd
(D) Pdx1 binds to the endogenous MafB Site 2 and Glucagon G1 regions in Mi
triplicate; control reactions were performed analyzing the IgG immunoprecipitati
(E) Simultaneous knock down of Pdx1 and MafB reveals that MafB is required
individual or combined knock down of Pdx1 and MafB by siRNA. nR3.
(F) Overexpression of MafB reveals that MafB is sufficient for the induction of e
of transcript levels from either control (Lenti-H2BCherry) or after MafB overexpre
Cell Met al., 2013). In the future, identifying ways to ‘‘reinduce’’ the self-
reinforcing transcriptional networks that maintain b cell identity,
including PDX1, may be a viable treatment strategy for treating
T2DM.
EXPERIMENTAL PROCEDURES
Animals
We used a Cre/LoxP system to specifically delete Pdx1 in the pancreatic b cell
lineage. Pdx1fl/fl mice (Ahlgren et al., 1998) were bred to the RIP-CreER strain,
which permits TAM-dependent recombination in b cells (Dor et al., 2004), to
create RIP-CreER; Pdx1fl/flmice. As some RIP-Cre strains have been reported
to exhibit recombination in cells other than pancreatic b cells (Wicksteed et al.,
2010), we sought to confirm the specificity of labeling within the pancreas; to
this end, we counted more than 1,000 islet cells in 1 month post-TAM-treated
control animals (RIP-CreER; Pdx1L/+; RosaYFP) and did not find any Glu+/YFP+
cells. This result demonstrates that within the pancreas, the RIP-CreER strain
is b cell specific.RIP-CreER animals were further bred toRosaYFPmice (JAX) to
generate RIP-CreER; Pdx1fl/fl; RosaYFP mice (PKO mice), permitting lineage
tracing of Pdx1-deleted cells. To activate recombination, five daily doses
of TAM (6 mg each) in corn oil were given by oral gavage to 30-day-old
animals. Under these conditions, the labeling efficiency was 91% (expressed
as percent of Ins+ cells that become YFP+ in RIP-CreER; RosaYFP control
animals). As controls, we used animals with one intact Pdx1 allele (i.e., RIP-
CreER; Pdx1fl/+, RosaYFP mice). Results are representative of six to seven
animals in either control or mutant groups unless otherwise described.
p values were calculated by Student’s t test. For glucose tolerance testing,
control and PKO underwent an overnight fast. The next morning, 2 g/kg
body weight of 20%D-glucose was given by intraperitoneal (IP) injection, after
which blood glucose level was measured by glucometer at 15, 30, 60, and
120 min. All studies were conducted in accordance with the policies of the
National Institutes of Health and the University of Pennsylvania Institutional
Animal Care and Use Committee guidelines.
Islet Studies
Calcium flow parameters of islet cells were measured by dual-wavelength
fluorescence microscopy using a Zeiss AxioVision system as indicator of
cell-type-specific response to either glycine, AAMs, or glucose. Dispersed
single islet cells were first incubated with Fura-2AM for 30 min and then
perfused with different stimuli. Cytosolic calcium flux was calculated based
on the 340/380 nm emission ratio, which served as an indicator of cell stimu-
lation. For hormone secretion measurements, 35 islets from either control or
PKO mice were incubated with various stimuli (0.4 mM AAM or 4 mM AAM +
10 mM Glucose) for 1 hr and tested for either insulin or glucagon secretion
by HFRF assay (Cisbio).
Histological Analysis and Immunostaining
For immunostaining of cultured Ins-1 cells, cells were washed with PBS, fixed
in a 3.2%paraformaldehyde/PBS, permeabilized with 0.2%Triton X-100/PBS,
and then stained overnight with primary antibodies to insulin, glucagon, and
MafB. For immunostaining histological sections, pancreas tissues were fixedEliminating Pdx1 Promoter Binding, with the Increased MafB Protein
Pdx1 siRNA illustrating how efficient reduction in Pdx1 protein (assessed by
n cellular staining while decreasing insulin staining.
r and bona fide glucagon G1 element (Wang et al., 2001). Core homeodomain
2 in gel shifts, and both endogenous Site 2 and G1 regions by ChIP.
binding toMafB Site 2. Competition with wild-type andmutant Site 2, as well as
x1:Site 2 and the supershifted (SS) complex is indicated.
n6 cells. ChIP assays and corresponding qPCR reactions were performed in
on and albumin promoter binding. nR3.
for glucagon expression in Ins-1 cells. qPCR data from Ins-1 cells following
ndogenous glucagon expression in Ins-1 b cells, as shown by qPCR analysis
ssion (Lenti-MafB-2ACherry). See also Table S6.
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and sectioning at 5 mm thickness, followed by immunostaining as previously
described (Zong et al., 2009). Primary antibody sources and application
were as following: Goat anti-GFP (Abcam) at 1:500; Chicken anti-GFP (Abcam)
at 1:500; Guinea pig anti-insulin (Abcam) at 1:500; Rabbit anti-glucagon
(Millipore) at 1:500; Rabbit anti-Pdx1 (Abcam) at 1:500; Rabbit anti-somato-
statin (DAKO) at 1:500; Rabbit anti-MafB (Bethyl Laboratories) at 1:2,000;
Goat anti-PP (Everest) at 1:500; Rabbit anti-ghrelin (Beta Cell Biology
Consortium) at 1:500; Rabbit anti-Arx(Gift from Dr. Kanako Miyabayashi) at
(1:1,000); and Rabbit anti-caspase-3 (Cell Signaling) at 1:1,000.
For electron microscopy, pancreas samples were fixed in 2.5% glutaralde-
hyde, 2.0% paraformaldehyde, and 0.1 M sodium cacodylate buffer (pH 7.4)
overnight at 4C. After subsequent buffer washes, the samples were postfixed
in 2.0% osmium tetroxide for 1 hr at room temperature and rinsed in distilled
H2O prior to en bloc staining with 2% uranyl acetate. After dehydration
through a graded ethanol series, the tissue was infiltrated and embedded in
EMbed-812 (Electron Microscopy Sciences, Fort Washington). Thin sections
were stained with uranyl acetate and lead citrate and examined with a JEOL
1010 electron microscope fitted with a Hamamatsu digital camera and AMT
Advantage image capture software.
Microarray and Quantitative RT-PCR Analysis
For the collection of RNA from b cells or lineage-labeled Pdx1 knockout cells,
PKOmice (RIPcreER; PDX1fl/fl,RosaYFP) and control mice (RIPcreER;PDX1fl/+,
RosaYFP) were given TAM and sacrificed 5 days later. Islets were isolated and
dispersed into a single cell suspension by standard techniques before being
sorted for YFP+ cells. For collection of RNA from a cells, glucagon-Cre mice
(Herrera, 2000) were crossed to RosaYFP mice. Single-cell suspensions were
made from islets derived from bigenic animals of the appropriate genotype.
Total RNA was extracted from YFP+ cells using an RNeasy total RNA isolation
Kit (Qiagen) according to manufacturer’s protocol. A total of 500 ng of total
RNA was used for the synthesis of cDNA, followed by amplification and biotin
labeling. A total of 1.5 mg of biotinylated cRNAs was hybridized to the Mouse
Gene 1.0ST microarray. After staining with streptavidin-phycoerythrin and
biotinylated anti-streptavidin, samples were scanned and data collected by
GCS3000 laser scanner. Statistical analyses were performed using Partek
Genomics Suite. A heatmap of expression was generated by Treeview (Eisen
et al., 1998). Quantitative RT-PCR analysis was carried out using SYBR
green gene expression assays (QIAGEN) according to the manufacturer’s
instructions.
Adenoviral Pdx1 Knockdown, Mobility Shift Assays, Chromatin
Immunoprecipitation, and MafB Overexpression
Ins-1 cells/well (7.5 3 105) were seeded into six-well plates and siRNAs
against MafB or scrambled control (Dharmacon) were introduced into cells
using Lipofectamine 2000 (Invitrogen). Adenovirus expressing GFP or the
Pdx1 siRNA was mixed with serum-free Dulbecco’s modified Eagle’s medium
to a concentration of 53 107 IFU/ml and infected for 48 hr before harvesting for
immunofluorescence, protein, and RNA analysis. Nuclear extract from bTC3
cells was prepared as described previously (Schreiber et al., 1989), and bind-
ing analysis was performed with double-stranded mouse oligonucleotides
(MafB Site 1 1,335 GCTTGGATCAGCTTAATCCTTACAAAACGT 1,306,
Site 2 952 CCCCACCGCATACATTAGCGCAGACAGAGC 923, and Site 2
mutant (MafB site 1 mt: 952 GCTCTGTCTGCGCGCCGGTATGCGGTGGGG
923; mutated bases are underlined). Competition analysis was performed
with at 1003molar excess of unlabeled competitor to labeled probe. Antibody
supershift analyses were performed by preincubating nuclear extract protein
with Pdx1 antibody prior to adding probe. Samples were electrophoresed
on 6% nondenaturing polyacrylamide gels at 150 V for 2 hr in 13 TBE buffer
(Tris-borate-EDTA). Gels were then dried and visualized by autoradiography.
ChIP assays were performed on three 10 cm plates of 60% confluent Min6
cells as described previously (Raum et al., 2006). Quantitative real-time PCR
was performed on immunoprecipitated DNA using SYBR Green master mix
and a Roche LightCycler 480II. Primers used for amplification were as follows:
MafB site1: Forward 938 TTAGCGCAGACAGAGCTACCGAAA 915,
Reverse 742 ATACTCTTTACACTCCCACCCTCG 765; Glucagon G1 ele-
ment: Forward148 CGTAAAAAGCAGATGAGCAAAGTG125, Reverse +46
GAACAGGTGTAGACAGAGGGAGTCC +70; Albumin distal TAAT-containing270 Cell Metabolism 19, 259–271, February 4, 2014 ª2014 Elsevier Inregion: Forward 3,342 TGGGAAAACTGGGAAAACCATC 3,319, Reverse
3,164 CACTCTCACACATACACTCCTGCTG 3,188.
For ectopic expression studies, a MafB cDNA was cloned in-frame into a
lenti-H2BCherry vector via a viral 2A peptide (Gao et al., 2013), resulting in
simultaneous expression of MafB and an H2BCherry fluorescent marker.
Lentivirus was generated and used to infect INS-1 cells as described previ-
ously (Zong et al., 2009). RNA extraction and RT-PCR analysis were performed
as described previously (Gao et al., 2013). Lenti-H2BCherry-infected cells,
which express H2BCherry protein without MafB, were used as a control.
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